baber/WOPTO huggingface dataset:
Patent FI-20115086-A0 (FI)
Inventor: NYMAN SOEREN
Filed: 2011-01-28
Abstract: The objective of the invention is to improve synchronization of a generator set. The invention predicts phase angle difference at synchronous speed of the generator and adjusts a controller of the prime mover for accelerating the prime mover in such a way that the generator will be the in phase with the network at the synchronous speed as a response to the prediction. A generator breaker is commanded to be closed (at 43) when the phase angles, frequencies and voltages match.
Patent IL-106991-A0 (IL)
Title: Cable termination device and method
IPC: H01R4/72
Filed: 1993-09-13
Abstract: PCT No. PCT/GB93/01865 Sec. 371 Date Mar. 13, 1995 Sec. 102(e) Date Mar. 13, 1995 PCT Filed Sep. 3, 1993 PCT Pub. No. WO94/07282 PCT Pub. Date Mar. 31, 1994A device for terminating a cable having a screen and at least one inner conductor comprises: (i) a hollow electrically conductive outer body for terminating the screen of the cable, which has two open ends and which is provided with an internal screw thread that tapers from one of its open ends; (ii) a metallic coil, at least part of which is screwed into the tapering screw thread of the outer body and tapers towards a constriction at least when screwed into the tapering screw thread; and (iii) a conformable metallic foil in tubular form, at least part of which is located within the constriction of the metallic coil; the device being arranged so that the screen of the cable may be terminated by inserting an exposed portion of it into the tube of metallic foil and screwing the metallic coil further into the outer body by means of the tapering screw thread, thereby constricting the coil further and causing the metallic foil to tighten about the cable screen.
Patent IL-108910-A0 (IL)
Title: Crystalline ceftiofur free acid
IPC: A61K31/546
Filed: 1994-03-09
Abstract: PCT No. PCT/US94/01862 Sec. 371 Date Sep. 11, 1995 Sec. 102(e) Date Sep. 11, 1995 PCT Filed Mar. 7, 1994 PCT Pub. No. WO94/20505 PCT Pub. Date Sep. 15, 1994Anhydrous and crystalline free acid form of the cephalosporin antiobiotic ceftiofur, processes for its manufacture, and pharmaceutical composition containing it are provided.   <IMAGE>
Patent IL-133535-A0 (IL)
Title: Method for inhibiting bone resorption
IPC: A61P13/08
Filed: 1998-07-17
Abstract: Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.
Patent IL-133730-A0 (IL)
Title: Compounds and methods substituted benzanilides as ccr5 ligands
IPC: A61P11/06
Filed: 1998-07-01
Abstract: This invention relates to substituted benzanilides which are ligands, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for example, atopic dermatitis and allergies), rheumatoid arthritis, sarcoidosis and other fibrotic diseases, atherosclerosis, psoriasis, autoimmune diseases such as multiple sclerosis, and inflammatory bowel disease, all in mammals, by the use of substituted benzanilides which are CCR5 receptor antagonists. Furthermore, since CD8+ T cells have been implicated in COPD, CCR5 may play a role in their recruitment and therefore antagonists to CCR5 could provide potential therapeutic in the treatment of COPD. Also, since CCR5 is a co-receptor for the entry of HIV into cells, selective receptor ligands may be useful in the treatment of HIV infection.
Patent IL-138464-A0 (IL)
Title: Fluid processing system and method
IPC: A61M11/02
Filed: 1999-03-11
Abstract: This disclosure relates to a centrifugal vortex system for preparing a liquid, such as fuel and includes a chamber housing defining a vortex chamber. An array of tangential apertures are formed in the chamber housing to permit fluid to be turbulently introduced into the vortex chamber to create a vortical flow of fluid through the vortex chamber. In one embodiment, a plurality of vortex chambers are arranged in series to allow the fluid to pass through several vortex chambers. In other embodiments, the chamber housing may be stepped, textured, or both to increase the turbulence of the flow through the chamber. In yet another embodiment, a pressure differential supply jacket is provided to normalize the amount of flow through the tangential apertures according to the location of the apertures. A centrifuge chamber is also disclosed which has a plurality of output conduits on a bottom surface and a tapered extension member downwardly extending from a top surface to enhance the centrifugal flow of the fluid. Additionally, a bypass conduit is provided to selectively permit the flow to bypass one or more chambers.
Patent IL-138638-A0 (IL)
Title: Processes for preparing intermediates
IPC: C07C67/343
Filed: 1999-03-22
Abstract: The invention relates to processes for the preparation of compounds of formula (I), wherein R<1 >and R<2 >are as defined in the description.
Patent IL-143441-A0 (IL)
Title: Non-naturally occuring antigen arrays and processes for the preparation thereof
IPC: C12N7/01
Filed: 1999-11-30
Abstract: The invention provides compositions and processes for the production of ordered and repetitive antigen or antigenic determinant arrays. The compositions of the invention are useful for the production of vaccines for the prevention of infectious diseases, the treatment of allergies and the treatment of cancers. Various embodiments of the invention provide for a virus, virus-like particle, viral capsid particle, phage or recombinant form thereof coated with any desired antigen in a highly ordered and repetitive fashion as the result of specific interactions. In one specific embodiment, a versatile new technology based on a cassette-type system (AlphaVaccine Technology) allows production of antigen coated viral particles. Other specific embodiments allow the production of antigen coated hepatitis B virus-like particles or antigen coated Measles virus-like particles.
Patent IL-143570-A0 (IL)
Title: Synthesis of histamine dihydrochloride
IPC: C07D233/64
Filed: 1999-12-20
Abstract: The invention disclosed herein relates to the preparation of pharmaceutical grades of histamine dihydrochloride using a two step non-enzymatic synthetic method. The invention disclosed herein describes the synthesis of histamine dihydrochloride by the non-enzymatic decarboxylation of histidine and the step-wise conversion of the decarboxylated product to the dihydrochloride salt form. The invention disclosed herein considers a final product of histamine dihydrochloride containing less than each of the following: 0.8% <SMALLCAPS>L</SMALLCAPS>-histidine HCl monohydrate, 0.1% individual chromatographic impurities, and 2% total impurities, to be acceptable for pharmaceutical use.
Patent IL-148705-A0 (IL)
Title: Manufacture and use of an antibiotic/antibiotics (or:antibiotic(s) preparation
IPC: A61K47/12
Filed: 2002-03-14
Abstract: The present invention concerns the manufacture and use of an antibiotic/antibiotics preparation for human and veterinary medicine, for the treatment of local microbial infections in hard and soft tissue. The manufacture in accordance with the invention of an antibiotic/antibiotics preparation takes place according to the invention in that water, an amphiphilic component of a representative of the alkyl sulfates, aryl sulfates, alkylaryl sulfates, cycloalkyl sulfates, alkylcycloalkyl sulfates, alkyl sulfamates, cycloalkyl sulfamates, alkylcycloalkyl sulfamates, aryl sulfamates, alkylaryl sulfamates, alkyl sulfonates, fatty acid-2-sulfonates, aryl sulfonates, alkylaryl sulfonates, cycloalkyl sulfonates, cycloalkyl sulfonates, alkylcycloalkyl sulfonates, alkyl disulfates, cycloalkyl disulfates, alkyl disulfonates, cycloalkyl disulfonates, aryl disulfonates, alkylaryl disulfonates, aryl trisulfonates and alkylaryl trisulfonates, one or more antibiotic components from the group of aminoglycoside antibiotics, lincosamide antibiotics and tetracycline antibiotics, an organic auxiliary component and/or an inorganic auxiliary component and if need be at least one biologically active component are mixed together and shaped into molded elements, granulates, powders, foils, shaped masses and threads.
Patent IL-151750-A0 (IL)
Title: Active substance combinations having insecticidal and acaricidal properties
IPC: A01N57/28
Filed: 2001-03-15
Abstract: The invention relates to novel active compound combinations of certain cyclic ketoenols and certain active compounds that together have unexpectedly good insecticidal and acaricidal properties.
Patent RO-130418-A0 (RO)
Title: Production and utilization of ovotransferrin pc2 ()
Inventor: PĂTRAŞCU IONEL VICTOR
IPC: C07K14/79
Filed: 2015-01-13
Abstract: The invention relates to a method for preparing ovotransferrin used as a biological product with immunogenic properties. According to the invention, the method consists in immunizing conventional egg-laying hens with a mixture of purified proteins prepared from inactivated bacterial bodies, inactivated viruses or inactivated fungi in admixture with an adjuvant, by intramuscular administration, and an immunomodulator by oral administration in admixture with the fodder, the inoculation with antigen being performed three times, at intervals of 14 days, after which the eggs are collected, the egg white is separated and diluted with deionized water in a ratio of 1:1, the pH is adjusted to 4.5...5, followed by successive precipitation with ammonium sulphate and citric acid, wherefrom there results ovotransferrin which is subjected to the dialysis in relation to a solution of NaCl 0.15 M or it is purified and concentrated by filtration.
Patent RO-132325-A0 (RO)
Title: Inverter for calibrating radiation pyrometers with emitting body heated by electromagnetic induction
Inventor: CLOŢEA LUMINIŢA ROXANA
IPC: G01J5/12
Filed: 2017-07-31
Abstract: The invention relates to an inverter for calibrating radiation pyrometers with emitting body heated by electromagnetic induction. According to the invention, the inverter comprises a rectifier (1), an inverter bridge with MOSFET transistors (2), a LLC circuit (3), a PID-algorithm temperature regulator (4), a control circuit (5) and gate control and protection circuit (6), the emitting body being in direct contact with a standard thermocouple Th, connected to a digital temperature regulator which amplifies and linearizes the signal received from the thermocouple, displaying the temperature of the emitting body, where the regulator output is connected to the control circuit (5) which transmits pulses for the gate control (6) of the power transistors.
Patent AP-2003002830-A0 (AP)
Title: Activated water apparatus and methods
Inventor: PASKALOW GEORGE
IPC: C02F1/48
Filed: 2001-12-20
Abstract: An apparatus subjects water to waves from an RF plasma. This allows continuous production of "activated water" characterized by cluster sizes below about 4 molecules per cluster, water having pH below 4 or above 10, or water having ORP of less than -350 mV or more than -t- 800 mV. The basic frequency of Ihc plasma is preferably between 0.44 Mil/ and 40-68 Mil/, and the plasma is preferably modulated at a frequency between 10 kHz and 34 kHz. Flow rales typically range from 20 1/hr to about 2000 l/hr. Activated water can be used for many purposes, including antimicrobial cleaning of worktable, floor, wall, knife, transport and other surfaces, for example, in meat processing facilities and hospitals.
Patent MC-1767-A1 (MC)
Inventor: J E CASIDA
IPC: A01N55/00
Filed: 1986-09-22
Abstract: Bicyclo-[2,2,1]-heptanes, bicyclo-[2,2,2]-octanes and bicyclo-[2,2,3]-nonanes having 2 or 3 ring hetero atoms selected from 0, S and N, substituted at the 1-position by a 4-alkynylphenyl group and at the 4-position and optionally at the 3 and/or 5-position are valuable pesticides, particularly insecticides and acaracides. The compounds may be prepared by reacting an alkyne with the corresponding 4- iodophenyl substituted compound or by debromination of the corresponding 4-dibromomethylphenyl substituted compound.
Patent MA-21804-A1 (MA)
Inventor: WALKER GRAHAM
IPC: C07D413/14
Filed: 1990-04-10
Abstract: A compound of formula (I): <CHEM> in which Ro denotes an optionally substituted isoxazol-5-yl, fury-2-yl or fur-3-yl group, has anti-bacterial and anti-mycoplasmal activity and may be prepared by a variety of processes from suitable derivatives of monic acid A.
Patent MA-26705-A1 (MA)
Title: Derives d'hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
Inventor: MATTHEW MERRILL HAYWARD
IPC: A61P31/04
Filed: 1999-11-10
Abstract: DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US 02/12/1998 60/110,618 Voir en annexe le titre de l'invention et le texte de l'abrégé Dérivés d'hygromycine A nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant L'invention concerne des composés de formule : dans laquelle R1, R2, R3, X1 et X2 représentent divers radicaux. Elle concerne également un procédé pour leur préparation et des compositions pharmaceutiques les contenant. Application : utilisation de ces composés et compositions pour le traitement de diverses infections bactériennes et infections par des protozoaires et d'affections liées à ces infections.
Patent MA-37457-A1 (MA)
Inventor: MOHAMED DAOUDI
IPC: A61P7/12
Filed: 2014-10-24
Abstract: تركيب مُركّب مضاد للسكري تركيب مغذي واستعمالها.يتعلق الاختراع الحالي بمركبات لها خاصيات مضادة للسكري وهي كما يلي:: 1- في حالة التناقص 2 - في حالة التراجع .المركبات الغذّائية هي مواد 1 - مماثلي من الدقيق نوع 45 متخمّرة 2 - لا تحتوي على عناصر قد تعزز زيادة معدل السكر 3 - تحتوي على عناصر مثبطة لمعدل السكر 4 - تحتوي على عناصر مخفّضة للسكري.
Patent MA-37631-A1 (MA)
Title: Composition a base de plantes medicinales aphrodisiaques pour la stimulation des organes sexuels et pour le traitement des dysfonctions sexuelles liees a l'impuissance et a la frigidite
Inventor: EL ISMAILI EL IDRISSI LALA MERIEM
IPC: A61P15/10
Filed: 2014-12-09
Abstract: La présente invention concerne une nouvelle composition a base de plantesmédicinales aphrodisiaques pour la stimulation des organes sexuels en vued’augmenter le piaisir sexuel avec une action supplémentaire sur les dysfonctionssexuelles liées a |'impuissance chez i’homme et a la frigidité chez la femme. Cettecomposition comprend comme plantes médicinales sous forme de poudremicronisée le gingembre (zingiber officinale) et sous forme d’extraits secsstandardisés: i’extrait de damiana (turnera diffusa), i’extrait de ginseng rouge(panax ginseng), i’extrait de muira puama (ptychopetalum olacoides), i’extrait depyréthre d'afrique (anacyclus pyrethrum) et i’extrait de girofle (syzygiumaromaticum). Cette invention peut se présenter comme une formulation spéciaiepour femme en y rajoutant les extraits d’aichémii|e (alchemilla vulgaris) et decostus (saussurea costus) ou comme une formulation spéciaie homme en yrajoutant les extraits d’epiméde (epimedium grandiflora) et de tongkat ali(eurycoma iongifolia).Cette composition selon l’invention peut se présenter sous n’importe quelle formecompatible avec une absorption orale en une ou plusieurs prises journaliéres.Cette composition peut notamment étre un complément alimentaire.
Patent MA-38140-A1 (MA)
Title: Composition comprenant un agent de lutte biologique et un insecticide
Inventor: ANDERSCH WOLFRAM
IPC: A01N63/30
Filed: 2013-12-03
Abstract: La présente invention concerne une composition comprenant au moins un agent de lutte biologique choisi dans le groupe consistant en la souche 251 de paecilomyces lilacinus (agal no. 89/030550) et coniothyrium minitans con/m/91-08 (dsm 9660) et/ou un mutant de ces souches ayant toutes les caractéristiques d'identification de la souche respective, et/ou au moins un métabolite produit par la souche respective qui présente une activité contre les nématodes, les insectes et/ou les phytopathogènes, et au moins un insecticide (i) choisi dans le groupe consistant en des inhibiteurs d'acétylcholinestérase (ache), des agonistes du récepteur nicotinique de l'acétylcholine (nachr), des activateurs allostériques du récepteur nicotinique d'acétylcholine (nachr), des bloqueurs du canal du récepteur nicotinique d'acétylcholine (nachr) et des modulateurs du récepteur de ryanodine dans une quantité synergiquement efficace. En outre, la présente invention concerne une trousse de pièces comprenant ladite composition et l'utilisation de ladite composition.
Patent MA-39027-A1 (MA)
Title: Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifs
Inventor: JAGASIA RAVI
IPC: C07D471/04
Filed: 2014-11-07
Abstract: L'invention concerne des composés de formule générale (i), dans laquelle r
Patent MA-39587-A1 (MA)
Title: Système de cogénération de l'énergie électrique à partir d'un rayonnement solaire combinant un système photovoltaïque à concentration et un convertisseur thermoélectrique et son procédé de fabrication
Inventor: LAKSSIR BRAHIM
IPC: H01L31/052
Filed: 2016-12-28
Abstract: La présente invention concerne le domaine de la conversion de l'énergie solaire en électricité. Elle concerne en particulier un système de cogénération d'énergie électrique à partir d'un rayonnement solaire combinant un système photovoltaïque à concentration et un convertisseur thermoélectrique développé pour y être jumelé pour cogénérer de 'électricité par effet seebeck. Le système de l'invention comporte une lentille fresnel (l), des optiques secondaires (2), une cellule pv multi-jonctions (3), un circuit imprimé (4), un module seebek (5). Le rayonnement solaire est concentré par une série de lentilles fresnel (l) à hauteur de 1000x soleil, une matrice de puce photovoltaïque multi-jonctions (3) à rendement variant entre 40 à 50%. Une grande partie de la chaleur excessive sera convertie en électricité en cogénération par effet seebeck grâce à un module thermoélectrique (5) à haut rendement monté en face arrière du substrat
Patent UY-26997-A1 (UY)
Title: Alquinilamidas y aplicaciones terapéuticas de las mismas
Inventor: BENNANI YOUSSEF L
IPC: A61P25/28
Filed: 2001-10-31
Abstract: Compuestos de fórmula (I), novedosos y útiles para el tratamiento de la apoplejía, la migrana y los trastornos psiquiátricos.
Patent UY-30475-A1 (UY)
Title: Procedimientos para fabricar bromuro de 3(r)-(2-hidroxi-2,2-dietien-2-ilaxetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo[2.2.2]octano.
Inventor: LORENZO FRANCESCA PAJUELO
IPC: C07D453/02
Filed: 2007-07-09
Abstract: La invencinn consiste en un procedimiento que comprende llevar a cabo la reaccinn de cuaternarizacinn entre el rster 1-azabiciclo[2.2.2]oct-3(R)elico del rcido 2-hidroxi-2,2-ditien-2-ilacctico y el bromuro de 3-fenoxipropilo en un disolvente o mezcla de disolventes que tiene(n) un punto de ebullicnn de 50 a 210sC y que se selecciona(n) del grupo consistente en cetonas y cteres ceclicos. Se prefiere el uso de un unico disolvente. El procedimiento de la presente invencinn permite disminuir el tiempo de reaccinn y la cantidad de disolventes y reaccionantes de alquilacinn utilizados, al mismo tiempo que se aumenta el rendimiento y que se mantiene el nivel de impurezas.
Patent ES-178696-A1 (ES)
Title: Procedimiento de fabricacion de una masa aislante, plastica, imputrescible y anticorrosiva
Filed: 1947-06-28
Abstract: Procedimiento de fabricación de una masa aislante plástica imputrescible y anticorrosina caracterizada porque se utiliza una mezcla de una parte de un aceite o de una grasa mineral y de otra parte de un hidrocarburo aromático de punto de fusión más elevado que el del aceite o el de la grasa mineral y que puede disolverse en ésta última y separarse de la misma bajo forma cristalina de tal manera que cuando el aceite o la grasa mineral se funde los cristales de hidrocarburo no fundidos impiden que el aceite o la grasa mineral se escurra y constituyen un soporte en el interior del que el aceite o la grasa mineral son mantenidos.
Patent ES-179483-A1 (ES)
Title: MEJORAS EN ANTENAS PARA COMUNICACIoN POR RADIO
Filed: 1947-08-28
Abstract: Mejoras en antenas para comunicación por radio caracterizadas por una estructura de antena que lleva un núcleo ferromagnético el cual es perfectamente simétrico con respecto al eje de rotación del devanado de la estructura de la antena.
Patent ES-191668-A1 (ES)
Title: Un tostador de café, recuperador y concentrador de aromas
Filed: 1950-02-14
Abstract: Tostador de café recuperador y concentrador de aromas caracterizado por estar constituido por dos cuerpos esféricos A y B dotados de un orificio o boca de carga cuyo cierre ha de hacerse herméticamente. El cuerpo tostador A esta destinado a recibir uniformemente en toda su extensión la acción de una fuente de calor destinada a tostar el café; y el cuerpo B por el contrario del A deberá estar frio para que de esta forma se produzca la condensación del vapor formado en e1 cuerpo tostador (A) y que pasará del primero al. segundo mediante el tubo-eje M.
Patent ES-197680-A1 (ES)
Title: Un sistema de contraste visual del cambio de velocidades
Filed: 1951-05-01
Abstract: Sistema de contraste visual del cambio de velocidades caracterizado por el accionamiento de un órgano móvil solicitado permanentemente por un resorte de manera tal que al movimiento de dicho órgano esta en concordancia con el desplazamiento de los elementos de transmisión de un cambio de velocidades con accionamiento a pedal utilizándose dicho desplazamiento concordante para la verificación directa visual de la posición de aquél.
Patent ES-253958-A1 (ES)
Title: Novel n-heterocyclic compounds and methods for their preparation
Filed: 1959-12-05
Abstract: The invention comprises: (a) 3-alkanoyl-10,11-dihydro-5-dibenzo[b.f]azepines of the general formula <FORM:0912013/IV (b)/1> wherein X represents -CH2-CH2-and R1 an alkyl radical of 1-3 carbon atoms (b) the preparation of compounds I by reacting, in the presence of a Friedel-Crafts condensing agent, a 5-acyl-10,11-dihydro - 5 - dibenzo[b.f]azepine with a halide or anhydride of a C2-4 alkane-carboxylic acid and hydrolising the resulting 3-alkanoyl-5-acyl compound (c) the combination of (b) with the Wolff-Kishner reduction of the product to a compound of the general formula <FORM:0912013/IV (b)/2> (wherein X represents -CH2-CH2- and R2 an alkyl radical of 2-4 carbon atoms) by treatment with hydrazine and an alkali metal hydroxide or alcoholate and (d) the combination of (c) with the conversion of the products to the corresponding compounds in which X represents -CH=CH- by acylation to form an easily split 5-acyl derivative, reaction of this with halogen or a compound giving off halogen, reaction of the resulting 3-alkyl-5-acyl-10-halo compound with an agent splitting off hydrogen halide, and simultaneous or subsequent hydrolysis to remove the 5-acyl substituent. Compounds II are useful as intermediates for the synthesis of pharmaceuticals.
Patent ES-274839-A1 (ES)
Title: Stabilized cytochrome c and process for preparing the same
IPC: A61K47/18
Filed: 1962-02-22
Abstract: Cytochrome C is stabilized by incorporating with an aqueous solution thereof a stabilizing agent selected from a saccharide, a peptide and an amino acid containing more basic than acid groups. Ascorbic acid is preferably added prior to incorporation of the stabilizer. The saccharide may be d-glucose, d-galactose, d-fructose, d-mannose, l-sorbose, sucrose, maltose, d-sorbitol or l-mannitol the peptide may be glycylglycine, glycylglycylglycine, analylglycylglycine or leucylglycylglycine the amino acid may be histidine or lysine.